Dimitris Skokos

Title: Innovations and Contributions of Inventor Dimitris Skokos

Introduction

Dimitris Skokos is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of biomedicine. He holds a total of 14 patents, showcasing his innovative approach to developing therapeutic solutions for various diseases.

Latest Patents

Among his latest patents are the "Bispecific anti-PSMA x anti-CD28 antibodies and uses thereof." This invention provides bispecific antigen-binding molecules that specifically target human CD28 and PSMA, which are crucial for inhibiting the growth of tumors expressing PSMA, such as prostate tumors. These antibodies are designed to enhance targeted immune responses, making them beneficial for treating diseases where such responses are therapeutically advantageous. Another notable patent is the "EGFR x CD28 multispecific antibodies," which offers a combination therapy approach for treating cancers, particularly those expressing EGFR. This innovation combines tumor-targeted immunotherapy with PD-1 inhibition, promoting effective T cell activation without systemic cytokine secretion.

Career Highlights

Dimitris Skokos has worked with leading companies in the pharmaceutical industry, including Regeneron Pharmaceuticals, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in cancer therapies.

Collaborations

Throughout his career, Dimitris has collaborated with notable professionals in the field, including Andrew J Murphy and George D Yancopoulos. These collaborations have further enhanced his research and innovation capabilities.

Conclusion

Dimitris Skokos is a distinguished inventor whose work in developing bispecific antibodies and multispecific antibodies has the potential to revolutionize cancer treatment. His contributions reflect a commitment to advancing medical science and improving patient outcomes.